Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: AWD, PDT, ACC

ProFuse Technology Awarded ?2.4 Million EIC Grant to Accelerate Cultivated Meat Production


YOKNEAM, Israel, May 8, 2024 /PRNewswire/ -- ProFuse Technology, a leading developer of enabling technologies for the cultivation of muscle tissue, today announced it has been awarded a ?2.4 million grant from the European Innovation Council (EIC) Transition program. This prestigious grant recognizes ProFuse's innovative technology and its potential to revolutionize the cultivated meat industry.

Selected from a Competitive Pool: ProFuse was chosen for the EIC grant after a rigorous selection process involving hundreds of applicants. This recognition serves as a strong validation of ProFuse's technology and its value proposition within the cultivated meat landscape.

Grant to Fuel Growth and Regulatory Approval: Building on the successful validation of its technology with numerous cultivated meat producers, ProFuse recently launched two key products:  The PROFUSE-S1 media supplement, which accelerates and optimizes cultivated muscle growth, and the PROFUSE-B8 cell line, a unique bovine myoblast cell line that replicates indefinitely without genetic modification. 

The EIC grant will empower ProFuse to advance its muscle cultivation technology. This includes:

Government Support for Alternative Protein Innovation: Government funding plays a critical role in fostering innovation, particularly in capital-intensive industries like cultivated meat. This ?2.4 million grant, awarded to one company, is extraordinary in its size and thus is a good indication for the commitment of the European Union towards supporting the development of the promising alternative proteins sector.

About ProFuse Technology

ProFuse Technology specializes in creating solutions for muscle growth in the cultivated meat and life science industries. This includes the development of cell lines and media supplements. Our solutions not only increase yield and shorten production cycles but also lead to a substantial reduction in production costs.

The company actively collaborates with prominent cultivated meat and life-science companies, seamlessly integrating its solutions into their production processes for cultivated meat and in-vitro muscle models.

Established in 2021 under the FRESH START foodtech incubator, the company received investments from leading industry and financial investors. Its technology is based on six years of research carried out at the Tzahor Lab of the Weizmann Institute of Science. In October 2022, ProFuse secured an additional $3 million in seed funding, with Green-Circle, a New York-based foodtech fund, leading the investment.

About The Good Food Institute

The Good Food Institute Israel is a nonprofit think tank working to harness the power of local alternative protein research and innovation to target the world's climate, global health, food security, and biodiversity goals.

As a catalyst for the entire sector, GFI Israel leverages the Israeli entrepreneurial mentality and partners with forward-thinking scientists, businesses, and policymakers to advance research and industry breakthroughs and promote governmental support for alternative proteins.

Contact:
Guy Nevo Michrowski, CEO
ProFuse Technology Ltd.
+972 54 4449314
[email protected]
www.profuse-tech.com

Contact:
Ariella Charny, Director of Marketing & Communication
The Good Food Institute Israel
+972 54 4536837
[email protected]
www.gfi.org.il

SOURCE Profuse Technology


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: